ELMAS’s Theory of Medical Thermodynamics and the Fifth Law of Thermodynamics Based Closed-Loop Feedback Bio-Robotic Resonance Method and FM Modulated Smart Drug Algorithm in Glioblastoma - Brain Cancer Treatment

Abstract

Objective: Glioblastoma (GBM) is one of the most dangerous, invasive, and failing malignant tumors of the central nervous system. Despite current
surgical interventions, radiotherapy, and temozolomide-based treatment protocols, the average survival time of patients does not reach the desired level. The inadequacy of these treatments stems from biological and physical obstacles such as the degeneration of brain tissue by the tumor, the blood-brain barrier (BBB) preventing the passage of chemotherapeutic agents, and the significant mechanical damage caused to healthy organs. Traditional approaches treat the tumor only as a biochemical structure, ignoring its thermodynamic and mechanical properties. To overcome this, the integration of medical and engineering disciplines has become increasingly important. Emin Taner Elmas’s “ELMAS Medical Thermodynamics Theory” and its foundation, the
“5th Law of Thermodynamics,” posit that living tissues and defective structures exist as dynamic, open thermodynamic systems. For the preservation and integrity of its existence, a living cell must continuously absorb energy from the environment and release entropy. However, the uncontrollably proliferating glioblastoma system has an abnormally high metabolic rate and regulated entropy production compared to healthy growths. This chaotic state causes the tumor to emit unique microscopic heat and entropy fluctuations around it. By modeling these theoretical currencies at different levels, Elmas σdokuoffers a “Thermodynamic Signature” () that allows for the localization of the tumor.

In this study, the major challenges of conventional oncology applications—such as the blood-brain barrier, poor localization, and systemic side effects—are addressed through an interdisciplinary bio-robotic platform integrating medicine, control software, and mechanical engineering. Guided by the “ELMAS Medical Thermodynamics Theory” and the “5th Law of Thermodynamics” developed by Dr. Emin Taner Elmas, an integrated treatment and smart drug delivery architecture has been designed to destroy Glioblastoma (GBM) tumor cells without damaging healthy tissues.

Method: Within the scope of the research, the natural frequencies (fn) of healthy neurons and GBM cells were modeled at a differential level using damped
single-degree-of-freedom mechanical system equations. The proposed system incorporates the ELMAS Medi-Bio-Energy Tronic sensor matrix to detect entropy fluctuations emitted by micro-tumor foci, a closed-loop PID controller algorithm to lock the excitation frequency onto the tumor’s resonance range (85 - 120 kHz), and a 3D Phased Array Smart Helmet geometry for millimeter-scale energy focusing. Furthermore, a Frequency Modulated (FM) smart Nitinol micro-valve mechanism, triggered upon resonance verification (Activation Matrix = 1), and pumpless two-phase Medical Heat Pipes were integrated into the system architecture and futuristically simulated within the MATLAB/Simulink environment.

Findings: Computer-based dynamic simulation results demonstrated that the focused negative entropy balance (- Δ S) applied to the system
deterministically inhibits tumor metabolic growth. Time-dependent graphs proved that the mechanical displacement amplitude within the tumor cell
surges during resonance, exceeding the critical rupture threshold of 8.0 μm and achieving selective cellular lysis without injuring surrounding tissues.
The FM-modulated smart drug delivery mechanism released chemotherapeutic agents strictly at the target coordinates, theoretically reducing the risk of systemic toxicity to zero. Additionally, the heat pipes successfully stabilized local tissue temperatures below the critical cellular damage threshold of 41.5 °C in a stable phase, without requiring an external mechanical pump.

Conclusion: This study transforms Glioblastoma treatment from a biological uncertainty into a second-by-second manageable mechatronic automation problem. Following future in-vitro testing on agarose gel tissue phantoms and pre-clinical in-vivo validations, the proposed platform holds the potential to pioneer a new era not only in brain tumor therapies but also in the treatment of complex neurological disorders such as SMA, ALS, and Parkinson’s disease.